332 related articles for article (PubMed ID: 18677515)
1. Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer.
Langenkamp E; Molema G
Cell Tissue Res; 2009 Jan; 335(1):205-22. PubMed ID: 18677515
[TBL] [Abstract][Full Text] [Related]
2. Molecular heterogeneity of tumor endothelium.
Aird WC
Cell Tissue Res; 2009 Jan; 335(1):271-81. PubMed ID: 18726119
[TBL] [Abstract][Full Text] [Related]
3. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
Shojaei F; Ferrara N
Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for angiogenesis and antiangiogenic drugs in clinical oncology.
Bertolini F
Breast; 2009 Oct; 18 Suppl 3():S48-50. PubMed ID: 19914542
[TBL] [Abstract][Full Text] [Related]
5. Novel approaches in anti-angiogenic treatment targeting endothelial F-actin: a new anti-angiogenic strategy?
Thoenes L; Günther M
Curr Opin Mol Ther; 2008 Dec; 10(6):579-90. PubMed ID: 19051136
[TBL] [Abstract][Full Text] [Related]
6. The role of the microenvironment and intercellular cross-talk in tumor angiogenesis.
Jung YD; Ahmad SA; Liu W; Reinmuth N; Parikh A; Stoeltzing O; Fan F; Ellis LM
Semin Cancer Biol; 2002 Apr; 12(2):105-12. PubMed ID: 12027582
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic strategies for cancer therapy (Review).
Benouchan M; Colombo BM
Int J Oncol; 2005 Aug; 27(2):563-71. PubMed ID: 16010440
[TBL] [Abstract][Full Text] [Related]
8. Current insights on the biology and clinical aspects of VEGF regulation.
Birk DM; Barbato J; Mureebe L; Chaer RA
Vasc Endovascular Surg; 2008 Dec-2009 Jan; 42(6):517-30. PubMed ID: 18799497
[TBL] [Abstract][Full Text] [Related]
9. [Rationale of antiangiogenic therapy].
Tímár J; Paku S; Tóvári J; Döme B
Magy Onkol; 2006; 50(2):141-51. PubMed ID: 16888678
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms regulating the angiogenic phenotype in tumors: clinical impact in the future.
Aubry K; Barriere G; Chable-Rabinovitch H; Dutour A; Paraf F; Monteil J; Rigaud M
Anticancer Res; 2007; 27(5A):3111-9. PubMed ID: 17970051
[TBL] [Abstract][Full Text] [Related]
11. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
Wong ML; Prawira A; Kaye AH; Hovens CM
J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic gene therapy of cancer: current status and future prospects.
Persano L; Crescenzi M; Indraccolo S
Mol Aspects Med; 2007 Feb; 28(1):87-114. PubMed ID: 17306361
[TBL] [Abstract][Full Text] [Related]
13. Aquaporin-1: a novel promoter of tumor angiogenesis.
Clapp C; Martínez de la Escalera G
Trends Endocrinol Metab; 2006; 17(1):1-2. PubMed ID: 16309919
[TBL] [Abstract][Full Text] [Related]
14. Ischemic vascular disease and solid cancers: opposing ends of the angiogenic spectrum?
Balasubramanian SP; Reed MW
Med Hypotheses; 2006; 67(6):1317-9. PubMed ID: 16828237
[TBL] [Abstract][Full Text] [Related]
15. Tumor inflammatory angiogenesis and its chemoprevention.
Albini A; Tosetti F; Benelli R; Noonan DM
Cancer Res; 2005 Dec; 65(23):10637-41. PubMed ID: 16322203
[TBL] [Abstract][Full Text] [Related]
16. Molecular and cellular biomarkers for angiogenesis in clinical oncology.
Bertolini F; Mancuso P; Shaked Y; Kerbel RS
Drug Discov Today; 2007 Oct; 12(19-20):806-12. PubMed ID: 17933680
[TBL] [Abstract][Full Text] [Related]
17. Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature.
Fogal V; Sugahara KN; Ruoslahti E; Christian S
Angiogenesis; 2009; 12(1):91-100. PubMed ID: 19225898
[TBL] [Abstract][Full Text] [Related]
18. Angioarrestin: a unique angiopoietin-related protein with anti-angiogenic properties.
Dhanabal M; Jeffers M; LaRochelle WJ; Lichenstein HS
Biochem Biophys Res Commun; 2005 Jul; 333(2):308-15. PubMed ID: 15950186
[TBL] [Abstract][Full Text] [Related]
19. Targeted siRNA delivery to diseased microvascular endothelial cells: cellular and molecular concepts.
Kowalski PS; Leus NG; Scherphof GL; Ruiters MH; Kamps JA; Molema G
IUBMB Life; 2011 Aug; 63(8):648-58. PubMed ID: 21766413
[TBL] [Abstract][Full Text] [Related]
20. Circulating endothelial cells as biomarkers in clinical oncology.
Mancuso P; Bertolini F
Microvasc Res; 2010 May; 79(3):224-8. PubMed ID: 20176038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
